![RuCl2[(R)-DM-SEGPHOS® ][(R)-DAIPEN] molecular structure](/images/molecules/rucl2-r--dm-segphos-r--daipen--944450-43-5.png)
Ordering
Available Variants50 mg
CHA.78781-50mg
Price
€22.56
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.78781-50mg | €22.56 |
Professionally catalogued chemical listing prepared to support identification, technical review, safety visibility, and structured B2B sourcing workflows.
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C65H70Cl2N2O6P2Ru |
|---|---|
| CAS Number | 944450-43-5 |
| Molecular Weight | 1209.18 |
| NACRES | NA.22 |
| PubChem Substance ID | 329761482 |
| UNSPSC Code | 12352005 |
| MDL number | MFCD10567024 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
RuCl2[(R)-DM-SEGPHOS® ][(R)-DAIPEN] is a chiral ruthenium complex with the CAS number 944450-43-5, utilized as a catalyst in various asymmetric hydrogenation reactions. The complex features a ruthenium center coordinated to a DM-SEGPHOS ligand and a DAIPEN ligand, both of which are chiral and play a crucial role in inducing enantioselectivity in the catalytic process. This catalyst has been employed in the enantioselective hydrogenation of various substrates, including ketones, imines, and olefins, to produce chiral compounds with high optical purity. The efficiency and selectivity of RuCl2[(R)-DM-SEGPHOS® ][(R)-DAIPEN] make it a valuable tool in the field of asymmetric catalysis, particularly in the synthesis of pharmaceuticals and other biologically active compounds that require high enantioselectivity. Its applications continue to expand in the realm of organic synthesis.
